Srijon K. Banerjee, PhD
- Post Doctoral Associate
Why did you choose the University of Pittsburgh?
I chose the University of Pittsburgh for the collaborative environment and the diverse areas of research in the Microbiology and Molecular Genetics Department.
Education & Training
- PhD in Biotechnology, Bose Institute, University of Calcutta (India), 2017
- MS in Biotechnology, Amity University (India), 2010
- BS in Microbiology with Honors, St. Xavier's College Kolkata (India), 2008
Research Interests
Current research interest: Host-pathogen interactions and metabolic effectors of MRSA infections.
Previous research: Early host-pathogen interactions in pneumonic plague.
Publications
Dmitriev A, Chen X, Paluscio E, Stephens AC, Banerjee SK, Vitko NP, et al. (2021) The Intersection of the Staphylococcus aureus Rex and SrrAB Regulons: an Example of Metabolic Evolution That Maximizes Resistance to Immune Radicals. mBio. 12: e02188-21.
Banerjee SK, Chatterjee A, Gupta S and Nagar A. (2022) Activation and Regulation of NLRP3 by Sterile and Infectious Insults, Frontiers in Immunology. 13: 896353. doi:10.3389/fimmu.2022.896353.
Banerjee SK, Crane SD and Pechous RD. (2020) A dual role for the Plasminogen activator protease during the pre-inflammatory phase of primary pneumonic plague. The Journal of Infectious Diseases, jiaa094, https://doi.org/10.1093/infdis/jiaa094.
Banerjee SK, Huckuntod SD, Mills SD, Kurten RC and Pechous RD. (2019) Modeling Pneumonic Plague in Human Precision-Cut Lung Slices Highlights a Role for the Plasminogen Activator Protease in Facilitating Type 3 Secretion. Infection and Immunity. 87: e00175-19; DOI: 10.1128/IAI.00175-19.
Crane SD, Banerjee SK and Pechous RD. (2021) Pretreatment With Fluticasone Propionate Increases Antibiotic Efficacy During Treatment of Late-Stage Primary Pneumonic Plague. Antimicrobial Agents and Chemotherapy. AAC. 01275-21.